These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene. Kimchi-Sarfaty C; Marple AH; Shinar S; Kimchi AM; Scavo D; Roma MI; Kim IW; Jones A; Arora M; Gribar J; Gurwitz D; Gottesman MM Pharmacogenomics; 2007 Jan; 8(1):29-39. PubMed ID: 17187507 [TBL] [Abstract][Full Text] [Related]
3. ABCB1 gene polymorphisms and haplotype analysis in colorectal cancer. Panczyk M; Balcerczak E; Piaskowski S; Jamroziak K; Pasz-Walczak G; Mirowski M Int J Colorectal Dis; 2009 Aug; 24(8):895-905. PubMed ID: 19415305 [TBL] [Abstract][Full Text] [Related]
4. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I. Staatz CE; Goodman LK; Tett SE Clin Pharmacokinet; 2010 Mar; 49(3):141-75. PubMed ID: 20170205 [TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of genes encoding drug transporters or cytochrome P450 enzymes and association with clinical response in cancer patients: a systematic review. Kulma I; Boonprasert K; Na-Bangchang K Cancer Chemother Pharmacol; 2019 Nov; 84(5):959-975. PubMed ID: 31482229 [TBL] [Abstract][Full Text] [Related]
6. Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature. Wolking S; Schaeffeler E; Lerche H; Schwab M; Nies AT Clin Pharmacokinet; 2015 Jul; 54(7):709-35. PubMed ID: 25860377 [TBL] [Abstract][Full Text] [Related]
7. ABCB1 haplotypes but not individual SNPs predict for optimal response/failure in Egyptian patients with chronic-phase chronic myeloid leukemia receiving imatinib mesylate. Ali MA; Elsalakawy WA Med Oncol; 2014 Nov; 31(11):279. PubMed ID: 25301112 [TBL] [Abstract][Full Text] [Related]
8. Beyond Single Nucleotide Polymorphisms: Brazeau DA; Attwood K; Meaney CJ; Wilding GE; Consiglio JD; Chang SS; Gundroo A; Venuto RC; Cooper L; Tornatore KM Front Genet; 2020; 11():889. PubMed ID: 32849848 [TBL] [Abstract][Full Text] [Related]
9. Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients. Chang H; Rha SY; Jeung HC; Im CK; Ahn JB; Kwon WS; Yoo NC; Roh JK; Chung HC Ann Oncol; 2009 Feb; 20(2):272-7. PubMed ID: 18836089 [TBL] [Abstract][Full Text] [Related]
10. Mugosa S; Todorovic Z; Cukic J; Sahman-Zaimovic M; Djordjevic N Open Life Sci; 2021; 16(1):142-149. PubMed ID: 33817306 [TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic study of the impact of ABCB1 single-nucleotide polymorphisms on lenalidomide treatment outcomes in patients with multiple myeloma: results from a phase IV observational study and subsequent phase II clinical trial. Jakobsen Falk I; Lund J; Gréen H; Gruber A; Alici E; Lauri B; Blimark C; Mellqvist UH; Swedin A; Forsberg K; Carlsson C; Hardling M; Ahlberg L; Lotfi K; Nahi H Cancer Chemother Pharmacol; 2018 Jan; 81(1):183-193. PubMed ID: 29177954 [TBL] [Abstract][Full Text] [Related]
12. Influence of ABCB1 genetic variants in breast cancer treatment outcomes. Chaturvedi P; Tulsyan S; Agarwal G; Lal P; Agarwal S; Mittal RD; Mittal B Cancer Epidemiol; 2013 Oct; 37(5):754-61. PubMed ID: 23707158 [TBL] [Abstract][Full Text] [Related]
13. GSTP1 and ABCB1 Polymorphisms Predicting Toxicities and Clinical Management on Carboplatin and Paclitaxel-Based Chemotherapy in Ovarian Cancer. Ferracini AC; Lopes-Aguiar L; Lourenço GJ; Yoshida A; Lima CSP; Sarian LO; Derchain S; Kroetz DL; Mazzola PG Clin Transl Sci; 2021 Mar; 14(2):720-728. PubMed ID: 33326171 [TBL] [Abstract][Full Text] [Related]
14. Disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in relation to ABC transporter genotypes. Zamboni WC; Ramanathan RK; McLeod HL; Mani S; Potter DM; Strychor S; Maruca LJ; King CR; Jung LL; Parise RA; Egorin MJ; Davis TA; Marsh S Invest New Drugs; 2006 Sep; 24(5):393-401. PubMed ID: 16505951 [TBL] [Abstract][Full Text] [Related]
15. Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patients. Cusinato DA; Lacchini R; Romao EA; Moysés-Neto M; Coelho EB Br J Clin Pharmacol; 2014 Aug; 78(2):364-72. PubMed ID: 24528196 [TBL] [Abstract][Full Text] [Related]
16. ABCB1 variants confer susceptibility to primary open-angle glaucoma and predict individual differences to latanoprost treatment. Liu H; Yang ZK; Li Y; Zhang WJ; Wang YT; Duan XC Biomed Pharmacother; 2016 May; 80():115-120. PubMed ID: 27133047 [TBL] [Abstract][Full Text] [Related]
17. Effect of ABCB1 genetic polymorphisms on the transport of rivaroxaban in HEK293 recombinant cell lines. Sennesael AL; Panin N; Vancraeynest C; Pochet L; Spinewine A; Haufroid V; Elens L Sci Rep; 2018 Jul; 8(1):10514. PubMed ID: 30002384 [TBL] [Abstract][Full Text] [Related]
18. Association of genotypes and haplotypes of multi-drug transporter genes ABCB1 and ABCG2 with clinical response to imatinib mesylate in chronic myeloid leukemia patients. Au A; Aziz Baba A; Goh AS; Wahid Fadilah SA; Teh A; Rosline H; Ankathil R Biomed Pharmacother; 2014 Apr; 68(3):343-9. PubMed ID: 24581936 [TBL] [Abstract][Full Text] [Related]
19. Genetic variability among Mexican Mestizo and Amerindian populations based on three ABCB1 polymorphisms. Favela-Mendoza AF; Rangel-Villalobos H; Fricke-Galindo I; Ortega-Vázquez A; Martínez-Cortés G; López-López M Mol Biol Rep; 2018 Dec; 45(6):2525-2533. PubMed ID: 30317428 [TBL] [Abstract][Full Text] [Related]
20. The effect of ABCB1 polymorphisms on the outcome of breast cancer treatment. Tulsyan S; Mittal RD; Mittal B Pharmgenomics Pers Med; 2016; 9():47-58. PubMed ID: 27175090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]